Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Champions Oncology Inc
CSBRCurrent price
4.9 USD
-0.1 USD (-2.00%)
Last closed
4.79 USD
Company
www.championsoncology.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
68 580 720 USD
Yield for 12 month
-24.27 %
1Y
3Y
5Y
10Y
15Y
CSBR
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Address: One University Plaza, Hackensack, NJ, United States, 07601
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
+50 155 000 USD
Last Year
+53 870 000 USD
Current Quarter
+14 002 000 USD
Last Quarter
+12 019 000 USD
Current Year
-435 000 USD
Last Year
+24 338 000 USD
Current Quarter
-354 000 USD
Last Quarter
+4 170 000 USD
Key Figures CSBR
1 year
3 years
5 years
10 years
EBITDA
-5 054 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-14.31 %
PEG Ratio
–
Return On Equity TTM
-532.46 %
Wall Street Target Price
6 USD
Revenue TTM
50 155 000 USD
Book Value
-0.14 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
7.1 %
Dividend Yield
–
Gross Profit TTM
24 338 000 USD
Earnings per share
-0.54 USD
Diluted Eps TTM
-0.54 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-28.6 %
Profit Margin
-14.51 %
Dividend Analytics CSBR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CSBR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
12.08.2015
Dividend Date
–
Stock Valuation CSBR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
22.8833
Enterprise Value Revenue
1.4473
Price Sales TTM
1.3808
Enterprise Value EBITDA
-10.4677
Price Book MRQ
6.7705
Financials CSBR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CSBR
For 52 weeks
4.5 USD
7.13 USD
50 Day MA
4.85 USD
Shares Short Prior Month
52 212
200 Day MA
5.35 USD
Short Ratio
4.22
Shares Short
49 608
Short Percent
0.72 %
